Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.
After several challenging quarters, Regeneron's sales growth is rebounding. In the first quarter, the company's revenue rose ...
Investor's Business Daily on MSN
Why these four biotech stocks prove that follow-on entries still pop up in stock market leaders
AnaptysBio recorded $234 million in sales over the past four quarters.
The biotech group has struggled as a whole in 2025, but analysts say the innovation that has always supported the biotech ...
Smaller biotech stocks often fly under the radar. Many of them aren't consistently profitable, but some can deliver outsize ...
Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.
Odyssey Therapeutics secured a valuation of $899.9 million after its shares rose 11.1% in their Nasdaq debut on Friday, ...
Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...
Entrada identified lower-than-expected plasma exposure in juvenile DMD patients as the cause of the lackluster data. Exposure ...
Krystal Biotech delivered strong Q1 2026 results, with Vyjuvek sales up 32% YoY to $116.4M and gross margin expanding to 95%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results